Doxycycline as a means of decreasing abdominal aortic aneurysm growth: Will it work?

Gefasschirurgie

Volumn 7, Issue 4, 2002, Pages 240-243

  Baxter, B Timothy ^a   Johanning, Jason M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Abdominal aortic aneurysm (AAA); Diameter; Doxycycline; Imaging studies; Risk of rupture surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXYCYCLINE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROPRANOLOL; TETRACYCLINE DERIVATIVE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ANEURYSM SURGERY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; HUMAN; NONHUMAN; REVIEW;

EID: 0036935618     PISSN: 09487034     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00772-002-0237-4     Document Type: Review

References (26)

1. Alcorn HG et al. (1996) Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 16: 963-970
2. Goldstone JM (1998) Aneurysms of the aorta and iliac arteries. In: Wesley Moore MD (ed) Vascular surgery: a comprehensive review, 5th edn. W B Saunders, Philadelphia, pp 435-456
3. Melton LJ 3rd et al (1984) Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol 120: 379-386
4. Gomes MN, Choyke PL (1987) Pre-operative evaluation of abdominal aortic aneurysms: ultrasound or computed tomography? J Cardiovasc Surg (Torino) 28: 159-166
5. Lindholt JS et al. (1996) Hospital based screening of 65-73 year old men for abdominal aortic aneurysms in the county of Viborg, Denmark. J Med Screen 3: 43-46
6. Wilson KA et al. (1997) Expansion rates of abdominal aortic aneurysm: current limitations in evaluation. Eur J Vasc Endovasc Surg 13: 521-526
7. Lederle FA et al. (2002) Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346: 1437-1444
8. The UK Small Aneurysm Trial Participants (1998) Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352(9141): 1649-1655
9. Santilli SM et al. (2002) Expansion rates and outcomes for the 3.0-cm to the 3.9-cm infrarenal abdominal aortic aneurysm. J Vasc Surg 35: 666-671
10. Cook TA, Galland RB (1996) A prospective study to define the optimum rescreening interval for small abdominal aortic aneurysm. Cardiovasc Surg 4: 441-444
11. Ricci MA et al. (1996) Effects of hypertension and propranolol upon aneurysm expansion ir the Anidjar/Dobrin aneurysm model. Ann N Y Acad Sci 800: 89-96
12. Moursi MM et al. (1995) Inhibition of aortic aneurysm development in blotchy mice by beta adrenergic blockade independent of altered lysyl oxidase activity. J Vasc Surg 21: 792-799; discussion 799-800
13. Leach SD et al. (1988) Effect of beta-adrenergi blockade on the growth rate of abdominal aortic aneurysms. Arch Surg 123: 606-609
14. Gadowski GR, Pilcher DB, Ricci MA (1994) Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 19: 727-731
15. Propanalol Aneurysm Trial Investigators (2002) Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 35: 72-79
16. Moore G et al. (1999) Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (R5 132908). J Vasc Surg 29: 522-532
17. Bigatel DA et al.(1999) The matrix metallo proteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg 29: 130-138; discussion 138-139
18. Treharne GD et al.(1999) Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease. Br J Surg 86: 1053-1058
19. Curci JA et al.(1998) Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 28: 1082-1093
20. Petrinec D et al. (1996) Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 23: 336-346
21. Boyle JR et al. (1998) Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 27: 354-361
22. Prall AK et al. (2002) Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 35: 923-929
23. Ciancio S, Ashley R (1998) Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 12: 27-31
24. Curci JA et al. (2000) Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metallo-proteinases in patients with abdominal aortic aneurysms. J Vasc Surg 31: 325-342
25. Baxter BT et al. (2002) Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 36: 1-12
26. Mosorin M et al. (2001) Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34: 606-610